Vanguard Group’s SOC Telemed TLMD Stock Holding History
Bought
Maintained
Sold
Vanguard Group's TLMD Position: Q2 2022 in Review
Vanguard Group sold out of SOC Telemed (TLMD) in Q2 2022, closing a stake of 2,588,838 shares — an estimated $7.74M sold.
Vanguard Group first reported a position in TLMD in Q4 2020 and held it in 6 quarters. The position peaked at $15M in Q2 2021. 0 funds tracked by Wall St. Rank hold TLMD as of Q2 2022.
- Vanguard Group reported no remaining SOC Telemed position as of Q2 2022 after selling out during the quarter.
- Vanguard Group sold 2,588,838 SOC Telemed shares in Q2 2022, an estimated $7.74M.
- Vanguard Group first reported a position in SOC Telemed in Q4 2020 and held it in 6 quarters.
- Vanguard Group's SOC Telemed position peaked at $15M in Q2 2021.
- 0 funds tracked by Wall St. Rank held SOC Telemed as of Q2 2022.
Based on Vanguard Group's 13F filing for Q2 2022, filed 12 Aug 2022.